Sanofi (SNY) Stock Down 5% Despite AERIFY-1 Success
Sanofi (NASDAQ:SNY)’s shares fell 5% this week, even as the company announced positive results from its AERIFY-1 trial with Regeneron…
Sanofi (NASDAQ:SNY)’s shares fell 5% this week, even as the company announced positive results from its AERIFY-1 trial with Regeneron…
By Dominique Patton and Geert De Clercq PARIS (Reuters) -France’s Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for…